Targeting the hydrophobic region of pyroglutamate‐modified amyloid‐β by tyrocidine A prevents its nucleation–aggregation process and its “catalytic effect” on the Aβs aggregation

Authors

Weihan Qin

Published

August 1, 2024

Abstract

Pyroglutamate (pE)-modified amyloid-β (Aβ) peptides play a crucial role in the development of Alzheimer's disease. pEAβ

Supporters

Support the authors with ResearchCoin

Journal

Journal of Biochemical and Molecular Toxicology

Topics

DOI

10.1002/jbt.23800

Targeting the hydrophobic region of pyroglutamate‐modified amyloid‐β by tyrocidine A prevents its nucleation–aggregation process and its “catalytic effect” on the Aβs aggregation

Authors

Weihan Qin

Published

August 1, 2024

Abstract

Pyroglutamate (pE)-modified amyloid-β (Aβ) peptides play a crucial role in the development of Alzheimer's disease. pEAβ

Supporters

Support the authors with ResearchCoin

Journal

Journal of Biochemical and Molecular Toxicology

Topics

DOI

10.1002/jbt.23800

Paper

Paper

Paper

Paper

Targeting the hydrophobic region of pyroglutamate‐modified amyloid‐β by tyrocidine A prevents its nucleation–aggregation process and its “catalytic effect” on the Aβs aggregation

Abstract

Supporters

Journal

Topics

DOI

Targeting the hydrophobic region of pyroglutamate‐modified amyloid‐β by tyrocidine A prevents its nucleation–aggregation process and its “catalytic effect” on the Aβs aggregation

Abstract

Supporters

Journal

Topics

DOI